论文部分内容阅读
目的探讨支气管动脉内灌注化疗在肺癌中应用及临床疗效。方法回顾2005年10月至2008年3月采用支气管动脉内灌注化疗肺癌患者94例临床资料进行总结分析。结果94例治疗的患者中完全缓解CR者27例,占28.72%;部分缓解PR者38例,占40.42%;稳定SD者20例,占21.27%;病变进展PD者9例,占9.59%。有效率(CR+PR+SD)为90.41%。结论支气管动脉灌注疗法对于不能手术治疗或手术前局部化疗的肺癌患者,是一种直接有效的治疗方法,不但延长了患者的生存时间,减轻了患者的痛苦,同时也提供了肺癌治疗的新方法。
Objective To investigate the application of bronchial artery infusion chemotherapy in lung cancer and its clinical effect. Methods The clinical data of 94 patients with lung cancer treated with intra-bronchial artery infusion during October 2005 to March 2008 were retrospectively analyzed. Results Among the 94 patients treated with CR, 27 patients were completely relieved of CR, accounting for 28.72%. 38 patients were partially relieved (40.42%), 20 were stable SD (21.27%), and 9 were PD (9.59%). Effectiveness (CR + PR + SD) was 90.41%. Conclusions Bronchial arterial infusion is a direct and effective treatment for patients with lung cancer who can not be treated surgically or before surgery. It not only prolongs the patient’s survival time and alleviates the patient’s pain, but also provides a new method for the treatment of lung cancer .